Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Diabetes Mellitus, Type 2

methylprednisolone hemisuccinate has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tao, J; Wang, X; Xu, K; Zhong, Z1
Chakravarty, R; Krishnan, P; Ramadas, P; Sah, B1

Other Studies

2 other study(ies) available for methylprednisolone hemisuccinate and Diabetes Mellitus, Type 2

ArticleYear
Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Diabetes Mellitus, Type 2; Hearing Loss, Sudden; Humans; Methylprednisolone Hemisuccinate; Prospective Studies; Quality of Life; Treatment Outcome

2022
A Rare and Fatal Case of Viral Encephalitis in an Immunocompetent Host.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:2

    Topics: Brain; Depression; Diabetes Mellitus, Type 2; Encephalitis, Viral; Fatal Outcome; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyperlipidemias; Hypertension; Hypothyroidism; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Plasmapheresis; Treatment Outcome

2017